drugset / Trial / NCT01016210
The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)
Phase 4
Completed
60 enrolled
The Baruch Padeh Medical Center, Poriya
Ministry of Health, Israel · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To explore whether recombinant LH (rLH) supplementation (Leuveris) to recombinant follicle stimulating hormone (rFSH) following GnRH antagonist treatment has an advantage in infertile women with advanced reproductive ageing undergoing IVF-ET.
Timeline
- Start
- 2010-02
- Primary completion
- 2012-03
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Leuveris | Protein / enzyme biologic | — | — |
Indications
No indication recorded.